These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2468184)

  • 1. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Herbrecht R; Damonte JC; Dufour P; Maloisel F; Liu KL; Ortiz S; Bergerat JP; Oberling F
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):7-10. PubMed ID: 1384135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease.
    Brusamolino E; Castelli G; Pagnucco G; Orlandi E; Malagó D; Lazzarino M; Bernasconi C
    Haematologica; 1990; 75(4):340-5. PubMed ID: 1703510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
    Cabanillas F
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):11-3. PubMed ID: 1384134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
    Engelhard M; Meusers P; Brittinger G; Brack N; Dornoff W; Enne W; Gassmann W; Gerhartz H; Hallek M; Heise J
    Ann Oncol; 1991 Feb; 2 Suppl 2():177-80. PubMed ID: 1710919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
    Avilés A; Díaz-Maqueo JC; Torras V; Rodríguez L; López Vancell D
    Sangre (Barc); 1990 Aug; 35(4):245-9. PubMed ID: 1703327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of elderly patients with hematological malignancies].
    Saito H; Mizoguchi H
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1801-7. PubMed ID: 1381569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?
    Mazza P; Bocchia M; Zanchini R; Gherlinzoni F; Zinzani PL; Pileri S; Tura S
    Haematologica; 1991; 76(1):47-52. PubMed ID: 1711505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.
    Nowrousian MR; Anders CH; Niederle N; Nagel-Hiemke M; Moritz T; Seeber S; Schmidt CG
    Ann Oncol; 1991 Jan; 2 Suppl 1():25-30. PubMed ID: 1710486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of the antitumor effect after remission induction therapy for non-Hodgkin's lymphoma--an approach to a response-adapted therapy].
    Osato M; Aoyagi M; Waku S; Furusawa S; Shishido H
    Rinsho Ketsueki; 1990 Nov; 31(11):1780-6. PubMed ID: 1704933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas].
    Avilés A; Huerta J; Guzmán R; Zepeda G; Díaz-Maqueo JC
    Rev Invest Clin; 1990; 42(4):271-6. PubMed ID: 1708910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cisplatin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin's lymphoma of high grade malignancy. The Danish Lymphoma Study Group.
    Andersen J; Thorling K; Bentzen SM; Brincker H; Christensen BE; Pedersen M
    Acta Oncol; 1990; 29(8):995-9. PubMed ID: 1703769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
    Longo DL; DeVita VT; Duffey PL; Wesley MN; Ihde DC; Hubbard SM; Gilliom M; Jaffe ES; Cossman J; Fisher RI
    J Clin Oncol; 1991 Jan; 9(1):25-38. PubMed ID: 1702144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
    Fisher RI; Longo DL; DeVita VT; Hubbard SM; Miller TP; Young RC
    Ann Oncol; 1991 Jan; 2 Suppl 1():33-5. PubMed ID: 1710487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
    O'Reilly SE; Hoskins P; Klimo P; Connors JM
    Ann Oncol; 1991 Jan; 2 Suppl 1():17-23. PubMed ID: 1710485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
    Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
    Molnár Z; Fleischmann T
    Orv Hetil; 1992 Jun; 133(25):1561-3. PubMed ID: 1383902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results of hybrid chemotherapy of Hodgkin's disease using COPP/VBA].
    Schneider T; Molnár Z; Szántó I; Fleischmann T
    Orv Hetil; 1992 Oct; 133(43):2755-7. PubMed ID: 1383907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The COP-BLAM therapy for malignant lymphoma].
    Arai N; Hara A; Umeda M; Shirai T
    Rinsho Ketsueki; 1990 Jul; 31(7):951-7. PubMed ID: 1699008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.